期刊文献+

白细胞介素-20在类风湿关节炎患者血清中的表达及影响因素探讨 被引量:1

Study on expression of serum IL-20 and its influencing factors in patients with rheumatoid arthritis
暂未订购
导出
摘要 目的探讨白细胞介素-20在类风湿关节炎患者血清中的表达及影响因素。方法根据病情,将50例类风湿性关节炎患者分为活动期类风湿性关节炎组、缓解期类风湿性关节炎组,并设立对照组,通过酶联免疫吸附法检测其血清白介素-20水平并与红细胞沉降率、C反应蛋白、晨僵时间等临床生化指标间的关系。结果与对照组相比,类风湿性关节炎患者血清白介素-20水平明显升高(P<0.05)且以活动期类风湿性关节炎患者尤甚(P<0.05);血清白介素-20与晨僵时间、关节压痛指数、红细胞沉降率、C反应蛋白类风湿因子及X线分期均有相关性(P<0.05)。结论 IL-20可能与类风湿性关节炎的发生发展相关,并在一定程度上反映了类风湿性关节炎的活动情况。 Objective To explore the expression of serum IL - 20 and its influencing factors in patients with rheumatoid arthritis. Meth- ods Patients with rheumatoid arthritis were divided into RA in active phase group and RA in alleviative phase group according to condition of ill- ness, and control group was established at the same time. Serum level of IL - 20 had been examined, and relationship between serum level of IL - 20 and' clinical and biochemical indicators such as ESR, CRP, duration of morning stuffing etc were compared and analyzed. Results Serum level of IL - 20 in RA patients was significantly elevated compared with that of control group ( P 〈 O. 05 ), even it was much higher in patients with RA in active phase ( P 〈 O. 05 ) ; and serum level of lL - 20 was closely correlated to duration of morning stuffing, joint pain index, ESR , CRP , RF and X - ray staging. Conclusion Serum level of IL - 20 is probably related to the occurrence and development of rheumatoid arthritis, and it in a certain extent may reflect the activity of rheumatoid arthritis.
出处 《临床和实验医学杂志》 2012年第24期1936-1937,共2页 Journal of Clinical and Experimental Medicine
关键词 类风湿关节炎 白细胞介素-20影响因素 Rheumatoid Arthritis Interleukin - 20 Influencing factor
  • 相关文献

参考文献10

  • 1Firestein GS. Evolving concepts of rheumatoid arthritis [ J]. Nature,2003,423(6937): 356 -361.
  • 2Oen K, Malleson PN, Cabral DA, et al. Cytokine genotypes correlatewith pain and radiologically defined joint damage in patients with juven-ile rheumatoid arthritis[ J]. Rheumatology ( Oxford),2005,44 ( 9 ):1115-1121.
  • 3Annunziato F, Cosmi L,Santarlasci V, et al. Phenotypic and functionalfeatures of human Thl7 cells[ J]. J Exp Med, 2007,204(8) : 1849 -1861.
  • 4宋书林,苏敏,邓彩英,张慧芳,郭晓峰.曲安奈德联合甲氨蝶呤关节腔注射改善类风湿关节炎患者症状并降低关节滑液中MMP-3、TNF-α[J].临床误诊误治,2012,25(1):68-70. 被引量:5
  • 5吕军影,黄李平.类风湿关节炎的中西医结合治疗[J].现代中西医结合杂志,2009,18(24):2952-2953. 被引量:2
  • 6Blumberg H, Conklin D, Xu WF, et al. Interleukin 20: discovery, re-ceptor identification, and role in epidermal function[ J]. Cell, 2001,104(1): 9-19.
  • 7Hsu YH, Li HH, Hsieh MY, et al. Function of interleukin - 20 as aproinflammatory molecule in rheumatoid and experimental arthritis[ J].Arthritis Rheum, 2006,54(9) : 2722 -2733.
  • 8Mclnnes IB,Liew FY. Cytokine networks - towards new therapies forrheumatoid arthritis [J]. Nat Clin Pract Rheumatol,2005,1(1): 31 -39.
  • 9Hsing CH,Ho CL, Chang LY,et al. Tissue microarray analysis of inter-leukin -20 expression[ J]. Cytokine, 2006,35(1 -2) : 44 -52.
  • 10Kragstrup TW, Otkjaer K, Holm C,et al. The expression of IL -20 andIL - 24 and their shared receptors are increased in rheumatoid arthritisand spondyloarthropathy[ J]. Cytokine, 2008 ,41 (1 ) : 16 -23.

二级参考文献19

  • 1高素琴,孙俊凯,韩小敏,孟兆伟.磁共振成像在类风湿关节炎早期诊断中的应用[J].临床误诊误治,2007,20(4):88-88. 被引量:2
  • 2Alex P, Szodoray P, Arthur E, et al. Influence of in- traarticular corticosteroid administration on serum cyto- kines in rheumatoid arthritis[ J]. Clin Rheumatol, 2007, 26 ( 5 ) : 845-848.
  • 3Okada Y, Nagase H, Harris E D, et al. A metalloprotei- nase from human rheumatoid synovial fibroblasts that di- gests connective tissue matrix components. Purification and characterization[ J ]. J Biol Chem, 1986,261 ( 30 ) : 14245-14255.
  • 4Han Z, Boyle D L, Chang L, et al. c-Jun N-terminal ki- nase is required for metalloproteinase expression and joint destruction in inflammatory arthritis [ J]. J Clin Invest, 2001,108( 1 ) :73-81.
  • 5DiBattista J A, Martel Pelletier J, Wosu L O, et al. Glu- cocorticoid receptor mediated inhibition of interleukin-1 stimulated neutral metalloprotease synthesis in normal hu-man chondrocytes[ J]. J Clin Endocrinol Metab, 1991,72 (2) :316-326.
  • 6Mamehara A, Sugimoto T, Sugiyama D, et al. Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological dis- ease modifying anti-rheumatic drugs [ J ]. Kobe J Med Sci, 2010,56(3) :98-107.
  • 7Grom A A, Murray K J, Luyrink L, et al. Patterns of ex- pression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthrop- athy[ J]. Arthritis Rheum, 1996,39(10) :1703-1710.
  • 8Sugano M, Tsuchida K, Tomita H, et al. Increased pro- liferation of endothelial cells with overexpression of solu- ble TNF-alpha receptor I gene [ J ]. Atherosclerosis, 2002, 162( 1 ) :77-84.
  • 9Lagnocco A, Cerioni A, Coari G, et al. Intra-articular methotrexate in the treatment of rheumatoid arthritis and psoriatic arthritis: a clinical and sonographic study [ J ]. Clin Rheumatol, 2006,25 (2) : 159-163.
  • 10Kane D, Gogarty M, Oleary J, et al. Reduction of syno- vial sublining layer inflammation and proinflammatory cy- tokine expression in psoriatic arthritis treated with metho- trexate [ J ]. Arthritis Rheum, 2004,50 ( 10 ) : 3286-3295.

共引文献5

同被引文献15

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部